Donor Selection - The Gatekeepers' Rules
-
Core Principle: Maximize graft survival while minimizing disease transmission.
-
General Criteria: Hemodynamic stability, absence of irreversible organ damage.
-
Absolute Contraindications:
- Uncontrolled systemic infection (sepsis).
- Most extracranial malignancies.
- HIV infection (though evolving with the HOPE Act).
- Prion diseases (e.g., CJD).
-
Relative Contraindications:
- Advanced age (> 70-80 years, varies by organ).
- Hepatitis B/C (can donate to positive recipients).
- Treated, localized cancers with long disease-free interval.
- Significant comorbidities (severe HTN, DM).
⭐ Primary non-metastasizing brain tumors (e.g., low-grade astrocytoma) generally DO NOT preclude organ donation.
Organ-Specific Criteria - Matchmaking Organs
-
Heart & Lungs:
- Primary: ABO compatibility & size matching (height, weight ±20%).
- Heart: Panel Reactive Antibody (PRA) < 10%.
- Lungs: Lung Allocation Score (LAS) guides priority based on urgency/benefit. Donor must have clear chest imaging and no aspiration.
-
Liver:
- Primary: ABO compatibility & size.
- Priority set by MELD/PELD score.
- Absence of extrahepatic malignancy or uncontrolled sepsis.
-
Kidney:
- Primary: ABO compatibility & Human Leukocyte Antigen (HLA) matching.
- Negative complement-dependent cytotoxicity (CDC) crossmatch is mandatory.
- PRA screens for pre-formed anti-HLA antibodies.
⭐ For kidneys, HLA-DR matching is the most critical for long-term graft survival, followed by HLA-B and then HLA-A.
Infection Screening - Dodging Dangerous Donations
- Core Serologies: Mandatory screening for all potential donors.
- HIV-1/2 (Antibody & NAT)
- Hepatitis B (HBsAg, anti-HBc, NAT)
- Hepatitis C (Anti-HCV, NAT)
- Syphilis (e.g., RPR)
- Viral Panel:
- CMV (IgG) - critical for matching
- EBV (VCA IgG)
- HTLV-1/2
- Targeted Screening: Based on exposure/geography.
- West Nile Virus (NAT)
- Trypanosoma cruzi (Chagas disease)
- SARS-CoV-2
⭐ Nucleic Acid Testing (NAT) is vital for detecting recent infections (HIV, HBV, HCV) during the serological "window period," especially in donors with high-risk behaviors.
Special Cases - Expanded Criteria Donors
- Donors aged > 60 years, or aged > 50 years with at least two of the following:
- History of hypertension (HTN)
- Terminal creatinine > 1.5 mg/dL
- Death from cerebrovascular accident (CVA)
- ECD organs carry a higher risk of graft dysfunction and failure but expand the donor pool, offering a survival benefit over waiting.
⭐ Despite increased risks, accepting an ECD kidney provides a significant mortality benefit compared to remaining on the transplant waitlist, especially for older recipients.
High‑Yield Points - ⚡ Biggest Takeaways
- ABO compatibility is the most critical initial step in donor selection, a non-negotiable prerequisite.
- HLA matching, particularly for HLA-A, B, and DR loci, is crucial for long-term graft survival, especially in kidney and bone marrow transplants.
- Absolute contraindications include active infections (HIV, viral hepatitis), uncontrolled sepsis, and most malignancies.
- Donor age is a significant factor; organs from very young or elderly donors may have reduced function.
- Hemodynamic stability and adequate end-organ function are essential for deceased donors.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app